Key facts
- This page summarizes Boxer Capital Management, LLC's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Oct 2024, 20:49.
Boxer Capital Management, LLC - 18 Oct 2024 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)
- Reporting relationship
- Other*
- Issuer ticker
- TYRA
- Reported as of
- 18 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Oct 2024, 20:49:28 UTC
- Prior SEC filing
- 22 Oct 2024
- Next SEC filing
- 23 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Aaron I. Davis, Managing Member, Boxer Capital Management, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Boxer Capital Management, LLC filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 22 Oct 2024.
Change
- Previous filing in this sequence was filed on 22 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TYRA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -2,000,000
- Change %
- -31%
- Price
- Shares after
- 4,448,359
- Date
- 18 Oct 2024
- Ownership
- See footnote
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TYRA
transaction
Derivative
Pre-Funded Warrant (right to purchase)
Award
- Transaction value
- Shares
- +2,000,000
- Change %
- +284%
- Price
- Shares after
- 2,705,280
- Date
- 18 Oct 2024
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 2,000,000
- Exercise price
- $0.001000
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Boxer Capital Management, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
On October 18, 2024, Boxer Capital, LLC ("Boxer") entered into an exchange agreement with the Issuer, pursuant to which Boxer agreed to exchange 2,000,000 shares of the Issuer's Common Stock for a pre-funded warrant to purchase up to 2,000,000 shares of Common Stock (the "Pre-Funded Warrant"). The Pre-Funded Warrant was issued on October 22, 2024.
Footnote F2
These securities are beneficially owned indirectly by Boxer Capital Management, LLC ("BCM") as the investment manager of Boxer. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Footnote F3
The Pre-Funded Warrant has no expiration date and is exercisable at any time after the date of issuance. A holder of the Pre-Funded Warrant may not exercise the Pre-Funded Warrant if the holder, together with other persons whose beneficial ownership is aggregated for purposes of Section 13 or Section 16 under the Securities Exchange Act of 1934, as amended, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise.
SEC remarks
The Reporting Person is a member of a group that formerly beneficially owned more than 10% of the outstanding shares of the Issuer's Common Stock.